Blar i forfatter Det helsevitenskapelige fakultet "Holte, Espen"
-
Automatic measurements of left ventricular volumes and ejection fraction by artificial intelligence reduces time-consumption and inter-observer variability
Olaisen, Sindre Hellum; Espeland, Torvald; Smistad, Erik; Hu, Jieyu; Pasdeloup, David Francis Pierre; Østvik, Andreas; Amundsen, Brage H.; Aakhus, Svend; Rösner, Assami; Stylidis, Michael; Holte, Espen; Grenne, Bjørnar Leangen; Løvstakken, Lasse; Dalen, Håvard (Conference object; Konferansebidrag, 2023-06-19) -
Automatic measurements of left ventricular volumes and ejection fraction by artificial intelligence: clinical validation in real time and large databases
Olaisen, Sindre Hellum; Smistad, Erik; Espeland, Torvald; Hu, Jieyu; Pasdeloup, David Francis Pierre; Østvik, Andreas; Aakhus, Svend; Rösner, Assami; Malm, Siri; Stylidis, Michael; Holte, Espen; Grenne, Bjørnar Leangen; Løvstakken, Lasse; Dalen, Håvard (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-10-26)Aims - Echocardiography is a cornerstone in cardiac imaging, and left ventricular (LV) ejection fraction (EF) is a key parameter for patient management. Recent advances in artificial intelligence (AI) have enabled fully automatic measurements of LV volumes and EF both during scanning and in stored recordings. The aim of this study was to evaluate the impact of implementing AI measurements on acquisition ... -
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
Kleveland, Ola; Ueland, Thor; Kunszt, Gabor; Bratlie, Marte; Yndestad, Arne; Broch, Kaspar; Holte, Espen; Ryan, Liv; Amundsen, Brage H.; Bendz, Bjørn; Aakhus, Svend; Espevik, Terje; Halvorsen, Bente; Mollnes, Tom Eirik; Wiseth, Rune; Gullestad, Lars; Aukrust, Pål; Damås, Jan Kristian (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-06-29)<p><i>Aim</i>: To evaluate the effect of interleukin-6 inhibition with tocilizumab on the cytokine network in patients with acute non-ST-elevation myocardial infarction (NSTEMI).</p> <p><i>Methods</i>: 117 patients with acute NSTEMI were randomised to an intravenous infusion of 280 mg tocilizumab or placebo prior to coronary angiography. Blood samples were obtained at baseline, at 6 consecutive ...